Steatotic liver disease is associated with frailty and lower muscle density compared to other liver diseases in patients with cirrhosis evaluated for liver transplantation: a cross-sectional study

Read full text Summarise with VIRAT
Authors: Salomé Declerck, Maxence Lepour, Étienne Danse, Pierre Tréfois, Nicolas Lanthier, Géraldine Dahlqvist, EASL-SLD-Summit-2026
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and aims: Myosteatosis, defined as reduced muscle density on computed tomography (CT) reflecting fat infiltration of skeletal muscle, is a classical feature and an independent predictor of mortality in patients with cirrhosis. However, its relationship with the underlying etiology of cirrhosis remains unclear. Our aim is to characterize muscle alterations across etiological subtypes of cirrhosis, focusing on steatotic liver disease (SLD). Method: A total of 191 cirrhotic patients evaluated for liver transplantation were prospectively included. Frailty was assessed using the Liver Frailty Index (LFI). All patients underwent abdominal CT scan at the third lumbar vertebra level (L3) to assess the following muscle parameters: skeletal muscle area (cm2), skeletal muscle index (SMI, cm2/m2), skeletal muscle density (HU) and skeletal muscle density index (SMDI, HU/cm2). Results: Among the 191 patients, 124 had a SLD: 23 with metabolic dysfunction–associated steatotic liver disease (MASLD), 90 with alcohol-related liver disease (ALD), and 11 with mixed etiology (MetALD). The remaining 67 patients had other disease causes (viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, etc.). Patients with SLD were significantly older and had a higher body mass index (BMI) than non-SLD patients (61 vs 52 years; 27.7 vs 22.8 kg/m²; both p < 0.0001), even though they had similar MELD scores. They were also frailer according to the LFI (3.9 vs 3.5; p < 0.05). On imaging, SLD patients showed higher muscle area and SMI values than other etiologies (164 vs 141 cm²; 54 vs 47 cm²/m²; p = 0.0012 and p = 0.003, respectively). In contrast, muscle density and the skeletal muscle density index (SMDI) were significantly lower in SLD patients (42 vs 49 HU; 0.26 vs 0.35 HU/cm²; p = 0.0002 and p < 0.0001), indicating increased muscle fat infiltration. These differences remained significant after adjustment for sex, age, and BMI in multivariate analysis. Conclusion: Patients with cirrhosis display distinct muscle alterations depending on the underlying etiology. SLD is associated with a muscle phenotype characterized by increased muscle mass, greater fat infiltration and muscle function impairment, suggesting a specific metabolic-driven muscle profile unique to these etiologies. These findings suggest specific approaches to nutritional and metabolic management in SLD-related cirrhosis.

Fields of Study & Subjects

Nutrition and Health in Aging Liver Disease Diagnosis and Treatment Liver Disease and Transplantation

Publication details

Journal / source
DIAL (Catholic University of Leuven)
Publication date
1 January 2026
Language
EN